demonstrated that CRC patients with high pre-operative SDC1 levels were less responsive to 5-fluorouracil, oxaliplatin, irinotecan, cisplatin, or paclitaxel chemotherapy (17). This evidence concerns the gene SDC1 and colorectal carcinoma.